Yuqing J. Lou

241 West Huaihai Road
Huaihai, 200030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications

Fusogenic Liposome-Mediated Extracellular Vesicles MicroRNA Profiling for Lung Cancer Diagnosis.

Fusogenic Liposome-Mediated Extracellular Vesicles MicroRNA Profiling for Lung Cancer Diagnosis.

Journal: ACS nano
Published: April 07, 2026

Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial.

Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial.

Journal: BMJ open
Published: March 25, 2026

Advances in translational lung cancer research in 2025: a narrative review.

Advances in translational lung cancer research in 2025: a narrative review.

Journal: Translational lung cancer research
Published: February 27, 2026

Prognostic significance of continuing immunotherapy beyond progression in unresectable lung adenocarcinoma.

Prognostic significance of continuing immunotherapy beyond progression in unresectable lung adenocarcinoma.

Journal: Frontiers in immunology
Published: February 06, 2026

Regulation of neuronal invasion of small cell lung cancer by STMN2/β-alanine-controlled metabolic reprogramming.

Regulation of neuronal invasion of small cell lung cancer by STMN2/β-alanine-controlled metabolic reprogramming.

Journal: Cell reports
Published: November 10, 2025

Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification.

Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification.

Journal: Materials today. Bio
Published: October 30, 2025

Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerations.

Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerations.

Journal: Translational lung cancer research
Published: October 01, 2025

Machine learning prediction for AML based on 3D genome selected circRNA.

Machine learning prediction for AML based on 3D genome selected circRNA.

Journal: NPJ systems biology and applications
Published: September 07, 2025

Hinokitiol preferentially suppresses metastatic lung adenocarcinoma via TMDD1-mediated ferroptosis induction and iron-sulfur cluster inhibition.

Hinokitiol preferentially suppresses metastatic lung adenocarcinoma via TMDD1-mediated ferroptosis induction and iron-sulfur cluster inhibition.

Journal: Cancer letters
Published: June 29, 2025

Develop and assessment of a predictive model for the first-course efficacy of acute myeloid leukemia

Develop and assessment of a predictive model for the first-course efficacy of acute myeloid leukemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 27, 2025

Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study.

Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study.

Journal: Translational lung cancer research
Published: May 11, 2025

Efficacy of immunotherapy in advanced ALK-rearranged non-small cell lung cancer patients with disease progression on ALK-TKIs.

Efficacy of immunotherapy in advanced ALK-rearranged non-small cell lung cancer patients with disease progression on ALK-TKIs.

Journal: Translational lung cancer research
Published: April 30, 2025
Showing 1-12 of 103

Last Updated: 09/26/2026